Davidson A J, Hayes W S, Hartman D S, McCarthy W F, Davis C J
Department of Radiologic Pathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000.
Radiology. 1993 Mar;186(3):693-6. doi: 10.1148/radiology.186.3.8430176.
The authors studied the hypothesis that oncocytoma and adenocarcinoma of the kidney can be differentiated with computed tomographic (CT) criteria and that differences would become more apparent as tumors enlarged. On contrast material-enhanced scans, homogeneous attenuation throughout the tumor and a central, sharply marginated, stellate area of low attenuation were considered predictors of oncocytoma. Any area of decreased attenuation in the tumor except for a stellate, central area was used as a predictor of adenocarcinoma. Among oncocytomas larger than 3 cm in diameter, 67% exhibited the criteria for oncocytoma and 33% met the criterion for adenocarcinoma; among smaller oncocytomas, the respective results were 82% and 18%. Among adenocarcinomas larger than 3 cm in diameter, 84% fulfilled the criterion for malignancy and 16% were incorrectly predicted to be oncocytomas; among smaller adenocarcinomas, the respective results were 58% and 42%. The authors conclude that the CT criteria used are poor predictors of the diagnosis of oncocytoma or adenocarcinoma regardless of tumor size.
肾嗜酸细胞瘤和肾腺癌可通过计算机断层扫描(CT)标准进行鉴别,且随着肿瘤增大,差异会更加明显。在对比剂增强扫描中,肿瘤整体均匀强化以及中央出现边界清晰的星芒状低密度区被视为嗜酸细胞瘤的预测指标。肿瘤内除星芒状中央区外任何密度减低区域则被用作腺癌的预测指标。在直径大于3 cm的嗜酸细胞瘤中,67%符合嗜酸细胞瘤标准,33%符合腺癌标准;在较小的嗜酸细胞瘤中,相应结果分别为82%和18%。在直径大于3 cm的腺癌中,84%符合恶性标准,16%被错误地预测为嗜酸细胞瘤;在较小的腺癌中,相应结果分别为58%和42%。作者得出结论,无论肿瘤大小,所使用的CT标准对嗜酸细胞瘤或腺癌的诊断预测能力都很差。